Transaction Costs and Organizational Competences: Explaining the Governance Structure for Manufacturing Stage
Keywords:conceptual framework, pharmaceutical industry, firm boundaries.
AbstractThis article deals with the influence of transaction costs and organizational competences on the choice of governance structure for manufacturing stage in a productive system. The objective is to develop a conceptual model that explains the choice of supplier for manufacturing through transaction costs and organizational competences. Following earlier studies, the model proposes competences of the product´s owner influence the vertical scope in a relation moderated by transaction costs. The constructs in the model are: "governance structure", the dependent variable categorized as internal or external supplier, "transaction costs", measured by asset specificity of the product and bargain power of the firm in the manufacturing stage, and "competences on operations”, measured by experience and diversification of the firm. The study presents some methodological implications for applying the model in Brazilian pharmaceutical industry, through searching for secondary data on drugs and firms in a public database of the federal regulatory agency.
ARGYRES, N. & Zenger, T. R., (2011). Capabilities, transaction costs, and firm boundaries: An integrative theory (August 18, 2011). Organization Science, Forthcoming. http://ssrn.com/abstract=1961600. [Accessed December 1st, 2011] .
BARNEY, J. B. & Hesterly, W. (1996). Organizational economics: Understanding the relationship between organizations and economic analysis. IN: Clegg, S. R., Hardy, C. & Nord, W.R. (eds.) Handbook of organization studies. SAGE Publications, Newbury Park, CA.
BASTOS, V. (2006). Laboratórios farmacêuticos oficiais e doenças negligenciadas: perspectivas de política pública. Revista do BNDES, 13 (25), 269-298.
BATAGLIA, W. & Meirelles, D. S. (2009). Population ecology and evolutionary economics: toward an integrative model. Management Research, 7 (2): 87-101.
BATAGLIA, W., Silva, A. A. & Klement, C. (2011). As dimensões da imitação entre empresas: Um estudo na indústria de transformação brasileira. RAE. Revista de Administração de Empresas, 51 (2): 160-174.
BATAGLIA,W.&Yu,A.S.O.(2008). Asincronizaçãodatomada de decisão estratégica com o planejamento estratégico formal. Revista de Administração Mackenzie, 9 (5): 82-111.
BECKER,M.C.(2004).Organizationalroutines:areviewofthe literature. Industrial and Corporate Change, 13 (4): 643-677.
BIGELOW, L.S. & Argyres, N. (2008). Transaction costs, industry experience and make-or-buy decisions in the population of early U.S. auto firms. Journal of Economic Behavior and Organization, 66 (3-4): 791-807.
BOGNER, W. (1996). Drugs to market: Creating value and advantage in the pharmaceutical industry. Oxford: Elsevier Science.
CALIARI, T. & Ruiz, R. (2010). Brazilian pharmaceutical industry and generic drugs: the political intentions and the unexpectedchanges.InAnaisdoDRUIDSummerConference 2010, Imperial College London Business School, Londres, Jun 2010. http://www2.druid.dk/conferences/viewabstract.php?id=500870&cf=43 [Accessed October 15, 2010] .
CAPANEMA, L. (2006). A indústria farmacêutica brasileira e a atuação do BNDES. BNDES Setorial, 23: 193-216.
COASE, R. H. (1937). The nature of the firm. Economica, 4 (16): 386-405.
CORIAT, B; Malerba F & Montobbio, F. (2004). The international performance of European sectorial systems. IN: MALERBA, F. Sectorial systems of innovation: concepts, issues and analyses of six major sectors in Europe. New York: Cambridge University Press.
CYERT, R. & March, J. (1963). A behavioural theory of the firm. Englewood Cliffs: Prentice Hall.
DI SERIO, L. C., Bento, R. D., Martins, G. S. & Duarte, A. L. de M. C. (2011). Strategic outsourcing? The Philips case in the LCD tv market. Journal of Technology Management and Innovation, 6 (2): 218-228.
DING, J., Xue, Y., Liang, H., Shao, R. & Chen, Y. (2011). From imitation to innovation: A study of China’s drug R&D and relevant national policies, Journal of Technology Management and Innovation, 6 (2): 1-12.
DOSI, G.; Nelson, R. & Winter, S.G. (2000). Introduction: The nature and dynamics of organizational capabilities. IN DOSI, G.; Nelson, R. & Winter, S.G. Nature and dynamics of organizational capabilities: 1-22. New York: Oxford University Press.
DOSI, G. & Teece, D. (1993).Organizational competence and the boundaries of the firm, CCC Working Paper No.
-11, UC-B, CRM.
EISENHARDT, K. & Schoonhoven, C. (1996). Strategic alliance formation in entrepreneurial firms: strategic needs and social opportunities for cooperation. Organizational Science, 7 (2): 136-150.
FERREIRA, I. M. P. (2010). A influência das competências organizacionais e do ambiente na formação dos grupos estratégicos no setor farmacêutico brasileiro, segmento de saúde humana. M.Sc Dissertation, São Paulo, SP. Centro de Ciências Sociais Aplicadas, Universidade Presbiteriana Mackenzie.http://www.mackenzie.br.[AccessedJuly01,2010] .
HENDERSON, R & Cockburn, I. (1994). Measuring competence? Exploring firm effects in pharmaceutical research. Strategic Management Journal, 15 (Winter Special Issue): 63-84.
HERNÁNDEZ-CUEVAS, C. (2007). Collaborative innovation: The future of biopharma. Journal of Technology Management and Innovation, 2 (3): 1-3.
HOETKER, G. (2005). How much you know versus how well I know you: selecting a supplier for a technically innovative component. Strategic Management Journal, 26 (1): 75-96.
JACOBIDES, M.G. & Winter, S.G. (2005). The co-evolution of capabilities and transaction costs: explaining the institutional structure of production. Strategic Management Journal, .26 (5): 395-413.
JOSKOW, P. (2005). Vertical integration. IN: MÉNARD, C & Shirley, M. Handbook of New Institutional Economics: 319-348. Dordrecht: Springer.
KLEIN, B., Crawford, R.G., & Alchian, A.A. (1978). Vertical integration, appropriable rents, and the competitive contracting process. Journal of Law and Economics, 21 (2):297-326.
KOGUT, B. (1988). Joint venture: theoretical and empirical perspective. Strategic Management Journal, 9 (4): 319-332.
KOGUT, B. & Zander, U. (1992). Knowledge of the firm, combinative capabilities, and the replication of technology. Organization Science, 3 (3): 383-397.
MACHER, J.T. & Richman, B.D. (2008). Transaction cost economics: an assessment of empirical research in the social sciences. Business and Politics, 10 (1):1-63.
MALERBA, F. (2004). Sectorial systems of innovation: concepts, issues and analyses of six major sectors in Europe. New York: Cambridge University Press.
MCKELVY, M; Orsenigo, L & Pammolli, F. (2004). Pharmaceuticals analysis through the lens of a sectorial innovation system. IN: MALERBA, F. Sectorial systems of innovation: concepts, issues and analyses of six major sectors in Europe. New York: Cambridge University Press.
MÉNARD, C., (2006). Hybrid oganization of production and distribution. Revista de Analisis Economico, 21(2): 25-41.
MOMIGLIANO, F. & Balcet, G. (1983). New trends in internationalization: processes and theories: diversified patterns of multinational enterprise and old and new forms of foreign involvement of the firm. Economic Notes, 12 (3): 42-68.
MONTEVERDE, K. & Teece, D. (1982). Supplier switching cost and vertical integration in the US automobile industry. Bell Journal of Economics, 13 (1): 206-13.
NAKAMURA, K. & Odagiri, H. (2005). R&D boundaries of the firm: an estimation of the double-hurdle model on commissioned R&D, joint R&D, and licensing in Japan. Economics of Innovation and New Technology, 14 (7): 583-615.
NELSON, R. & Winter, S. (1982). An evolutionary theory of economic change. Cambridge : Harvard University Press.
NOGUEIRA, A. C. L. (2011). Estratégia e estrutura no setor farmacêutico: o caso do Laboratório Aché. In D. S. Meirelles (Ed.), Formação e evolução da grande empresa brasileira: Estudos de caso embasados nas teorias da firma: 219-246. São Paulo: Universidade Presbiteriana Mackenzie.
PISANO, G. (1991). The governance of innovation: vertical integration and collaborative arrangements in the biotechnology industry. Research Policy, 20 (3): 237-249.
POWELL, W.W; Koput, K.W. & Owen-Smith, J., (1996). Interorganizational collaboration and the locus of innovation: network of learning in biotechnology. Administrative Science Quarterly, 41 (1): 116-145.
QUENTAL, C.; Abreu, J.C.; Bomtempo, J.V. & Gadelha, C.A.G. (2008). Medicamentos genéricos no Brasil: impactos das políticas públicas sobre a indústria nacional. Ciência e Saúde Coletiva, 13 (Supl.): 619-628.
REVE, T. (1990). The firm as a nexus of internal and external contracts. In AOKI, M., Gustafsson, B. & Williamson, O.E. (orgs.) The firm as nexus of treatis: 133-161. London: Sage Publications.
RUESTER, S., (2010). Recent developments in transaction cost economics. Resource Markets Working Paper No. RM-18. SSRN: http://ssrn.com/abstract=1535903 [Accessed March 02, 2010] .
RUMELT, R. P. (1982). Towards a strategic theory of the firm. In LAMB, R.B. (ed.) Competitive strategic management: 566-570. Englewood Cliffs: Prentice Hall.
SILVA, C. L. & Oliveira, A. (2007). Brazilian industry policy after 1990: focusing on the pharmaceutical industry. Journal of Technology Management and Innovation, 2 (3): 71-84.
SIMON, H.A. (1951). A formal theory of the employment relationship. Econometrica, 19 (3): 293-305.
TEECE, D.J; Pisano, G. & Shuen, A. (1997) Dynamic capabilities and strategic management. Strategic Management Journal, 18 (7): 509-533.
WHO Collaborating Centre for Drug Statistics Methodology (2010), Guidelines for ATC classification and DDD assignment 2011. Oslo.
WILLIAMSON, O.E. (1975). Market and hierarchies: analysis and antitrust implications. New York: The Free Press.
WILLIAMSON, O.E. (1999). Strategy research: governance and competence perspectives. Strategic Management Journal. 20: 1087-1108.
WILLIAMSON, O.E. (1985). The economic institutions of capitalism: firms, markets and relational contracting. New York: The Free Press.
WILLIAMSON, O.E. (1979). Transaction cost economics: the governance of contractual relations. Journal of Law and Economics, 22 (12): 233-261.
How to Cite